Skip to Content

Notice

Prospective Grant of a Partial Exclusive License: Recombinant Heregulin PE-40 Toxin Cancer Therapeutics Which Bind to the Ligand Binding Site of the erbB3 and/or erbB4 Proteins

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

The full text of this document is currently available in PDF format.

The full text of this document is also available in a basic text format.